氨基葡萄糖使用与肺癌风险的关系:英国生物银行全国性前瞻性队列研究
p<0.001)及肺癌死亡率降低(HR 0.88,95%CI 0.81-0.96;p=0.002)显著相关,有肺癌家族史者关联更强。
要点
- 规律使用氨基葡萄糖与肺癌风险降低显著相关(HR 0.84)。
- 氨基葡萄糖使用与肺癌死亡率降低显著相关(HR 0.88)。
- 有肺癌家族史者中氨基葡萄糖与肺癌风险的关联更强。
核心结论
- 规律使用氨基葡萄糖与肺癌风险降低及肺癌死亡率降低显著相关。
主要发现
- 随访期间记录1971例(0.45%)肺癌事件。
- 完全调整模型中,氨基葡萄糖使用与肺癌风险降低显著相关(HR 0.84,95%CI 0.75-0.92;p<0.001)。
- 氨基葡萄糖使用与肺癌死亡率降低显著相关(HR 0.88,95%CI 0.81-0.96;p=0.002)。
- 与无肺癌家族史者相比,有肺癌家族史者中氨基葡萄糖使用与肺癌风险降低的关联更强。
临床怎么用
- 在评估肺癌风险时,可将氨基葡萄糖使用史作为参考因素之一,尤其对有肺癌家族史者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Research on glucosamine shows anti-inflammatory and anti-cancer benefits with minimal adverse effects. We aimed to explore the relationship between use of glucosamine and risk of lung cancer and lung cancer mortality based on data from the large-scale nationwide prospective UK Biobank cohort study. METHODS: Participants were enrolled between 2006 and 2010 and followed-up to 2020. The Cox proportional hazards model was used to assess the relationship between glucosamine use and risk of lung cancer and lung cancer mortality. Subgroup analyses and sensitivity analyses were performed to explore the potential effect modifications and the robustness of the main findings. RESULTS: 439 393 participants (mean age 56 years; 53% females) with a mean follow-up of 11 years were included for analyses. 82 603 (18.80%) participants reported regular use of glucosamine at baseline. During follow-up, 1971 (0.45%) lung cancer events were documented. Glucosamine use was significantly associated with a decreased risk of lung cancer (hazard ratio (HR) 0.84, 95% CI 0.75-0.92; p<0.001) and lung cancer mortality (HR 0.88, 95% CI 0.81-0.96; p=0.002) in fully adjusted models. A stronger association between glucosamine use and decreased lung cancer risk was observed in participants with a family history of lung cancer when compared with those without a family history. CONCLUSION: Regular use of glucosamine was significantly related with decreased risk of lung cancer and lung cancer mortality, based on data from this nationwide prospective cohort study.
引用
- Li G, Zhang X, Liu Y, et al. Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study. Eur Respir J. 2022. PMID: 34326189. doi:10.1183/13993003.01399-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。